Ausnutria annual results 2025 and adjustments production organization

Zwolle, 27 March 2026 – The Ausnutria Group has published its 2025 annual results. Revenue increased by 1.2% to RMB 7,488 million (EUR 912.3 million), while operating profit (EBITDA) decreased by 14.8% to RMB 518.1 million (EUR 63.1 million). One-off impairments and provisions had a negative impact on the results, as did the continued pressure from the reduced Chinese infant and toddler nutrition market.

As a result, net profit for 2025 declined by 24.8% to RMB 177.5 million (EUR 21.6 million). The overall market situation requires adjustments to the effectiveness and efficiency of Ausnutria Netherlands’ production organization, with consequences for jobs in Leeuwarden and Kampen. Ausnutria Netherlands shared the proposed changes with its employees yesterday.

Market developments
After a stable first half of 2025, during which financial results improved compared to the previous year, pressure increased in the second half of the year. Declining production volumes are mainly the result of ongoing pressure in the Chinese market, where the stagnating birth rate continues to affect demand. This slowed Ausnutria’s revenue development in China, despite maintaining a strong market position.

At the same time, Ausnutria achieved strong growth with its Kabrita brand outside China, including in the Middle East, the United States, Canada, Mexico and Southeast Asia. Kabrita’s revenue outside China increased by 50.7% to RMB 327.7 million, representing a 27.4% share of this segment (2024: 17.5%).

This increasing international diversification contributes to a more robust and future-proof revenue base.

Impact on the production organization
Ausnutria Netherlands intends to adjust its production organization in the Netherlands due to the decline in demand from China, which is not yet sufficiently offset by growth in other markets and opportunities to broaden the product portfolio. As part of this, Ausnutria plans to reduce production capacity for infant and toddler nutrition at its factory in Leeuwarden. This is expected to result in the loss of 41 positions, including 20 permanent roles.

At the Kampen factory, the intention is to scale back certain activities, with part of the current production capacity for infant and toddler nutrition being repurposed for the production of ingredients for the food industry. This will result in 17 positions being affected, without impact on permanent roles.

With these adjustments, Ausnutria aims to restore the balance between production capacity and demand, broaden its focus, and strengthen the long-term resilience of the organization.

Remco Zieleman, CEO of Ausnutria Netherlands:
“We realize that these changes represent a significant impact for some of our colleagues. At the same time, we want to ensure that our organization remains future-proof. To achieve this, it is necessary to strengthen our financial foundation and adjust the way our organization is structured. Our core activity – producing high-quality infant and toddler nutrition – remains central to everything we do.”

Care for employees
All proposed decisions are subject to advice or approval by the (Central) Works Council. Ausnutria supports affected employees throughout this process. Where possible,
redeployment within the organization will be explored. For employees impacted by these changes, the applicable social plan will come into effect.

Outlook
Ausnutria will continue to focus on international growth, broadening its product portfolio, and strengthening its global market position in a dynamic and demanding sector. For 2026, growth in both revenue and profit is expected.